SCHEMBL10079528

SCHEMBL10079528

COC1CC(=O)c2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 2/20 0.53
MAPT P10636 5/20 0.41
TP53 P04637 4/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 1/20 0.41
HTR2B P41595 1/20 0.41
RAB9A P51151 5/20 0.41
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
MAOA P21397 1/20 0.41
PTGS2 P35354 1/20 0.41
ACHE P22303 2/20 0.40
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAOB P27338 1/20 0.39
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25567246 0.81 ACHE (0.50) S100A4MAPTTP53LMNARAB9A
SCHEMBL1567503 0.81 ACHE (0.58) MAPTLMNAACHEKDM4EALDH1A1
SCHEMBL29850498 0.81 ACHE (0.58) MAPTLMNAACHEKDM4EALDH1A1
SCHEMBL31660734 0.81 HTR2C (0.42) S100A4MAPTTP53LMNACYP1A2
SCHEMBL5108272 0.81 HTR2C (0.42) S100A4MAPTTP53LMNACYP1A2
SCHEMBL4795033 0.80 S100A4 (0.45) S100A4MAPTTP53LMNACYP1A2
Hydrochloric Acid SCHEMBL6601125 0.79 ACHE (0.56) MAPTHTR2BACHEKDM4EALDH1A1
SCHEMBL16377312 0.74 S100A4 (0.55) S100A4MAPTTP53LMNACYP1A2
SCHEMBL1093630 0.74 S100A4 (0.42) S100A4MAPTTP53LMNACYP1A2
SCHEMBL5319357 0.74 S100A4 (0.42) S100A4MAPTTP53LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018948-A2 NOVEL TREATMENT OF PROSTATE CARCINOMA PELLFICURE PHARMACEUTICALS, INC. (US) 2012-02-09 WO disclosed